Keywords: hafslund, nycomed, acquisition, acquired, most, pharmaceutical, portfolio

HAFSLUND NYCOMED ACQUISITION

Article | 07 February 1994

Print This

- Hafslund Nycomed has acquired most of the pharmaceutical portfolio of the German company Dorsch GmbH. The portfolio, which consists mainly ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in